FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2262744511> ?p ?o ?g. }

• W2262744511 endingPage "86" @default.
• W2262744511 startingPage "79" @default.
• W2262744511 abstract "Summary Reasons for performing study Our long‐term aim is to develop a gene therapy approach for the prevention of laminitis in the contralateral foot of horses with major musculoskeletal injuries and non‐weightbearing lameness. Objectives The goal of this study was to develop a practical method to efficiently deliver therapeutic proteins deep within the equine foot. Study design Randomised in vivo experiment. Methods We used recombinant adeno‐associated viral vectors (rAAVs) to deliver marker genes using regional limb perfusion through the palmar digital artery of the horse. Results Vector serotypes rAAV2/1, 2/8 and 2/9 all successfully transduced equine foot tissues and displayed similar levels and patterns of transduction. The regional distribution of transduction within the foot decreased with decreasing vector dose. The highest transduction values were seen in the sole and coronary regions and the lowest transduction values were detected in the dorsal hoof‐wall region. The use of a surfactant‐enriched vector diluent increased regional distribution of the vector and improved the transduction in the hoof‐wall region. The hoof‐wall region of the foot, which exhibited the lowest levels of transduction using saline as the vector diluent, displayed a dramatic increase in transduction when surfactant was included in the vector diluent (9‐ to 81‐fold increase). In transduced tissues, no significant difference was observed between promoters (chicken β‐actin vs. cytomegalovirus) for gene expression. All horses tested for vector‐neutralising antibodies were positive for serotype‐specific neutralising antibodies to rAAV2/5. Conclusions The current experiments demonstrate that transgenes can be successfully delivered to the equine distal extremity using rAAV vectors and that serotypes 2/8, 2/9 and 2/1 can successfully transduce tissues of the equine foot. When the vector was diluted with surfactant‐containing saline, the level of transduction increased dramatically. The increased level of transduction due to the addition of surfactant also improved the distribution pattern of transduction." @default.
• W2262744511 created "2016-06-24" @default.
• W2262744511 creator A5012131273 @default.
• W2262744511 creator A5023685155 @default.
• W2262744511 creator A5034055198 @default.
• W2262744511 creator A5051344823 @default.
• W2262744511 creator A5068239916 @default.
• W2262744511 creator A5085453358 @default.
• W2262744511 date "2016-01-16" @default.
• W2262744511 modified "2023-10-14" @default.
• W2262744511 title "Delivery and evaluation of recombinant adeno-associated viral vectors in the equine distal extremity for the treatment of laminitis" @default.
• W2262744511 cites W1513552803 @default.
• W2262744511 cites W1978072154 @default.
• W2262744511 cites W1980750032 @default.
• W2262744511 cites W1982293379 @default.
• W2262744511 cites W1988152924 @default.
• W2262744511 cites W1992203015 @default.
• W2262744511 cites W1992246699 @default.
• W2262744511 cites W2026039549 @default.
• W2262744511 cites W2047608515 @default.
• W2262744511 cites W2047667011 @default.
• W2262744511 cites W2058066097 @default.
• W2262744511 cites W2062249345 @default.
• W2262744511 cites W2075638876 @default.
• W2262744511 cites W2080951809 @default.
• W2262744511 cites W2091134968 @default.
• W2262744511 cites W2118249577 @default.
• W2262744511 cites W2148223197 @default.
• W2262744511 cites W2148389596 @default.
• W2262744511 cites W2152181618 @default.
• W2262744511 cites W2154330857 @default.
• W2262744511 cites W2170205772 @default.
• W2262744511 cites W4252092281 @default.
• W2262744511 cites W75666076 @default.
• W2262744511 doi "https://doi.org/10.1111/evj.12547" @default.
• W2262744511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7764945" @default.
• W2262744511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26663470" @default.
• W2262744511 hasPublicationYear "2016" @default.
• W2262744511 type Work @default.
• W2262744511 sameAs 2262744511 @default.
• W2262744511 citedByCount "7" @default.
• W2262744511 countsByYear W22627445112018 @default.
• W2262744511 countsByYear W22627445112019 @default.
• W2262744511 countsByYear W22627445112020 @default.
• W2262744511 countsByYear W22627445112021 @default.
• W2262744511 countsByYear W22627445112022 @default.
• W2262744511 crossrefType "journal-article" @default.
• W2262744511 hasAuthorship W2262744511A5012131273 @default.
• W2262744511 hasAuthorship W2262744511A5023685155 @default.
• W2262744511 hasAuthorship W2262744511A5034055198 @default.
• W2262744511 hasAuthorship W2262744511A5051344823 @default.
• W2262744511 hasAuthorship W2262744511A5068239916 @default.
• W2262744511 hasAuthorship W2262744511A5085453358 @default.
• W2262744511 hasBestOaLocation W22627445111 @default.
• W2262744511 hasConcept C104317684 @default.
• W2262744511 hasConcept C111599444 @default.
• W2262744511 hasConcept C141071460 @default.
• W2262744511 hasConcept C15152581 @default.
• W2262744511 hasConcept C151730666 @default.
• W2262744511 hasConcept C2778081065 @default.
• W2262744511 hasConcept C2778107364 @default.
• W2262744511 hasConcept C2779771469 @default.
• W2262744511 hasConcept C2780762169 @default.
• W2262744511 hasConcept C32470452 @default.
• W2262744511 hasConcept C40767141 @default.
• W2262744511 hasConcept C55493867 @default.
• W2262744511 hasConcept C71924100 @default.
• W2262744511 hasConcept C86803240 @default.
• W2262744511 hasConcept C92087593 @default.
• W2262744511 hasConceptScore W2262744511C104317684 @default.
• W2262744511 hasConceptScore W2262744511C111599444 @default.
• W2262744511 hasConceptScore W2262744511C141071460 @default.
• W2262744511 hasConceptScore W2262744511C15152581 @default.
• W2262744511 hasConceptScore W2262744511C151730666 @default.
• W2262744511 hasConceptScore W2262744511C2778081065 @default.
• W2262744511 hasConceptScore W2262744511C2778107364 @default.
• W2262744511 hasConceptScore W2262744511C2779771469 @default.
• W2262744511 hasConceptScore W2262744511C2780762169 @default.
• W2262744511 hasConceptScore W2262744511C32470452 @default.
• W2262744511 hasConceptScore W2262744511C40767141 @default.
• W2262744511 hasConceptScore W2262744511C55493867 @default.
• W2262744511 hasConceptScore W2262744511C71924100 @default.
• W2262744511 hasConceptScore W2262744511C86803240 @default.
• W2262744511 hasConceptScore W2262744511C92087593 @default.
• W2262744511 hasFunder F4320306716 @default.
• W2262744511 hasFunder F4320311927 @default.
• W2262744511 hasFunder F4320332161 @default.
• W2262744511 hasIssue "1" @default.
• W2262744511 hasLocation W22627445111 @default.
• W2262744511 hasLocation W22627445112 @default.
• W2262744511 hasOpenAccess W2262744511 @default.
• W2262744511 hasPrimaryLocation W22627445111 @default.
• W2262744511 hasRelatedWork W1553478374 @default.
• W2262744511 hasRelatedWork W1898773101 @default.
• W2262744511 hasRelatedWork W1965073684 @default.
• W2262744511 hasRelatedWork W2129891756 @default.
• W2262744511 hasRelatedWork W2168778618 @default.
• W2262744511 hasRelatedWork W2394624890 @default.

• next